Entera Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '18 Dec 31, 2018
Cash & Equivalents	7.11	8.66	11.02	12.31	7.51
Short-Term Investments	-	-	-	-	4.02
Cash & Short-Term Investments	7.11	8.66	11.02	12.31	11.52
Cash Growth	-17.92%	-21.41%	-10.48%	6.84%	-1.92%
Accounts Receivable	-	0.13	-	0.25	0.73
Other Current Assets	8.19	0.19	0.24	0.29	0.22
Total Current Assets	15.3	8.97	11.26	12.85	12.47
Net Property, Plant & Equipment	0.6	0.33	0.49	0.23	0.22
Other Intangible Assets	-	-	-	-	0.65
Other Long-Term Assets	0.1	0.09	0.02	0.05	-
Total Assets	15.99	9.39	11.77	13.13	13.34
Accounts Payable	0.45	0.13	0.08	0.02	-
Accrued Expenses	1.53	0.87	0.87	1.23	-
Current Portion of Leases	0.23	0.17	0.13	0.09	-
Unearned Revenue	-	-	-	-	0.23
Total Current Liabilities	2.2	1.18	1.09	1.34	1.79
Long-Term Leases	0.26	0.1	0.26	-	-
Other Long-Term Liabilities	0.43	0.03	0.03	0.03	1.44
Total Long-Term Liabilities	0.69	0.13	0.29	0.03	1.44
Total Liabilities	2.89	1.31	1.38	1.37	3.23
Common Stock	0	0	0	-	-
Additional Paid-in Capital	138.43	121.97	114.73	107.21	49.17
Accumulated Other Comprehensive Income	0.04	0.04	0.04	0.04	13.06
Retained Earnings	-125.37	-113.93	-104.39	-95.5	-52.12
Shareholders' Equity	13.1	8.08	10.39	11.75	10.12
Total Liabilities & Equity	15.99	9.39	11.77	13.13	13.34
Total Debt	0.49	0.27	0.39	0.09	0
Net Cash (Debt)	6.62	8.39	10.63	12.22	11.52
Net Cash Growth	-21.10%	-21.08%	-13.00%	6.05%	46.71%
Net Cash Per Share	0.14	0.22	0.37	0.42	1.44
Book Value	13.1	8.08	10.39	11.75	10.12
Book Value Per Share	0.28	0.21	0.36	0.41	1.27
Tangible Book Value	13.1	8.08	10.39	11.75	9.47
Tangible Book Value Per Share	0.28	0.21	0.36	0.41	1.19

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q